ImmunologybioRxivPreprint
Targeting HLA-E Positive Cancers with a Novel NKG2A/C Switch Receptor
M. L. Saetersmoen, I. Kotchetkov, L. Torralba-Raga…·K.-J. Malmberg
This paper develops a novel chimeric A/C switch receptor to target HLA-E positive cancers, showing enhanced anti-tumor activity while avoiding off-tumor toxicity.
DOI 10.1101/2023.12.14.571754